We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

1 hedge funds and large institutions have $16.2K invested in Zynerba Pharmaceuticals, Inc in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BRWA
B. Riley Wealth Advisors
Florida
+$16.2K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BRWA
1
B. Riley Wealth Advisors
Florida
$16.2K +$16.2K +12,732 New

ZYNE Hedge Fund Activity: Q1 2024 in Review

1 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Zynerba Pharmaceuticals, Inc (ZYNE) for Q1 2024, worth a combined $16.2K.

Buyers outnumbered sellers: 1 fund opened new ZYNE positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was B. Riley Wealth Advisors, opening a new position worth an estimated $16.2K.

  • 1 institutional investor held Zynerba Pharmaceuticals, Inc (ZYNE) as of Q1 2024, up from 0 in Q4 2023.
  • Funds reported $16.2K of Zynerba Pharmaceuticals, Inc stock for Q1 2024.
  • 1 fund opened new Zynerba Pharmaceuticals, Inc positions in Q1 2024 and 0 closed out, a net change of +1 holder.
  • The largest Zynerba Pharmaceuticals, Inc buyer in Q1 2024 was B. Riley Wealth Advisors, an estimated $16.2K added.

Based on aggregated 13F filings for Q1 2024.